His scientific interests lie mostly in Internal medicine, Endocrinology, Cholesterol, Risk factor and Lipoprotein. His Internal medicine research includes elements of Diabetes mellitus and Cardiology. His Cardiology study integrates concerns from other disciplines, such as Prospective cohort study, Obesity, Case-control study and Low-density lipoprotein particle.
His research integrates issues of Dyslipidemia and Confidence interval in his study of Cholesterol. His Risk factor research is multidisciplinary, incorporating elements of Odds ratio, Body mass index, Vascular disease, Blood plasma and Cohort. Benoît Lamarche interconnects Fibrinogen, Heart disease, Metabolism and Fatty acid in the investigation of issues within Lipoprotein.
His primary areas of investigation include Internal medicine, Endocrinology, Cholesterol, Apolipoprotein B and Lipoprotein. His Internal medicine study deals with Cardiology intersecting with Disease. The Cholesterol study combines topics in areas such as Abdominal obesity and Food science.
His Apolipoprotein B research is multidisciplinary, incorporating perspectives in Catabolism and Hepatic lipase. He focuses mostly in the field of Lipoprotein, narrowing it down to matters related to Familial hypercholesterolemia and, in some cases, LDL receptor. His Risk factor study incorporates themes from Diabetes mellitus and Prospective cohort study.
Benoît Lamarche mostly deals with Internal medicine, Endocrinology, Environmental health, Cholesterol and Food science. His research in Internal medicine intersects with topics in Eicosapentaenoic acid and Crossover study. As a part of the same scientific study, Benoît Lamarche usually deals with the Crossover study, concentrating on Single-nucleotide polymorphism and frequently concerns with Body mass index.
His works in Lipoprotein, Apolipoprotein B, Insulin resistance, Triglyceride and Familial hypercholesterolemia are all subjects of inquiry into Endocrinology. Benoît Lamarche usually deals with Environmental health and limits it to topics linked to Type 2 diabetes and Disease. In Cholesterol, he works on issues like Polyunsaturated fatty acid, which are connected to Metabolic syndrome and Randomized controlled trial.
His primary areas of study are Internal medicine, Endocrinology, Food science, Cholesterol and Environmental health. His Internal medicine study frequently links to other fields, such as Crossover study. His Endocrinology research incorporates themes from Eicosapentaenoic acid and Docosahexaenoic acid.
His work deals with themes such as Randomized controlled trial and Fatty acid, which intersect with Food science. His research on Cholesterol focuses in particular on Blood lipids. His research on Environmental health also deals with topics like
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Hyperinsulinemia as an Independent Risk Factor for Ischemic Heart Disease
Jean-Pierre Després;Benoît Lamarche;Pascale Mauriège;Bernard Cantin.
The New England Journal of Medicine (1996)
Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study.
B Lamarche;A Tchernof;S Moorjani;B Cantin.
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.
J Danesh;S Lewington;S G Thompson;Lowe Gdo..
Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?
Isabelle Lemieux;Agnès Pascot;Charles Couillard;Benoı̂t Lamarche.
Assessing Adiposity A Scientific Statement From the American Heart Association
Marc Andre Cornier;Jean Pierre Després;Nichola Davis;Daurice A. Grossniklaus.
Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study
B Lamarche;S Moorjani;P J Lupien;B Cantin.
Fasting Insulin and Apolipoprotein B Levels and Low-Density Lipoprotein Particle Size as Risk Factors for Ischemic Heart Disease
Benoît Lamarche;André Tchernof;Pascale Mauriège;Bernard Cantin.
Total Cholesterol/HDL Cholesterol Ratio vs LDL Cholesterol/HDL Cholesterol Ratio as Indices of Ischemic Heart Disease Risk in Men: The Quebec Cardiovascular Study
Isabelle Lemieux;Benoît Lamarche;Charles Couillard;Agnès Pascot.
JAMA Internal Medicine (2001)
Low-Density Lipoprotein Subfractions and the Long-Term Risk of Ischemic Heart Disease in Men 13-Year Follow-Up Data From the Québec Cardiovascular Study
Annie C. St-Pierre;Bernard Cantin;Gilles R. Dagenais;Pascale Mauriège.
Arteriosclerosis, Thrombosis, and Vascular Biology (2005)
The Dense LDL Phenotype: Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men
André Tchernof;Benoît Lamarche;Denis Prud'homme;André Nadeau.
Diabetes Care (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: